ArrowBack to Principal
News

Lilly-backed UK biotech raises $72M to advance its antibody approach

·
March 17, 2025
Media

Lilly-backed UK biotech raises $72M to advance its antibody approach

Contact

CEO
Email
Arndt Schottelius, MD. PhD, CEO
communications@maxion.co.uk
ICR Healthcare
Email
Mary-Jane Elliot / Ashley Tapp / Kate Hall
maxiontherapeutics@icrinc.com

Contact

Discovering transformational therapies

admin@maxion.co.uk

Follow us on:
Address

The Works, Suite 4 — Unity Campus
London Road
Cambridge, CB22 3FT
United Kingdom